Children's Hospital Medical Center, Cincinnati

This early study tests whether semaglutide, a drug already used for type 2 diabetes, can protect the body's insulin-producing cells in people with stage 1 type 1 diabetes. The goal is to see if it can delay or prevent the disease from progressing to the next stage. Fifteen adults…

This study looks at whether children and teens (ages 5-20) with mild rheumatic heart disease can stop taking monthly penicillin shots or pills without their heart condition getting worse. All 922 participants have already been on penicillin for at least 2 years and have stable or…

This study will test whether an artificial intelligence tool called RADAR can screen for rheumatic heart disease as well as or better than current methods. Researchers will enroll 62 nurse screeners at facilities in low-resource settings to see if RADAR can make screening easier …

This study compares two medications, methylphenidate and guanfacine, to see which works better for treating ADHD in children ages 3 to 5. Researchers will measure how much symptoms improve and how many children stop the medicine early. The goal is to find the safest and most effe…

This study tests whether a tailored program can help teens and young adults (ages 15-24) with cancer take their oral medications more consistently. Participants will use an electronic pill bottle to track adherence and complete surveys about their quality of life. The goal is to …

This study will test a virtual reality training program for doctors. The training helps doctors learn how to talk to parents about safely storing guns at home. About 30 pediatric doctors will try the training and share their thoughts on how useful and easy it is to use.